Your browser doesn't support javascript.
loading
O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.
Thiebaut, Audrey M; Louet, Estelle R; Ianszen, Mélina; Guichard, Marie-Julie; Hanley, Daniel F; Gaudin, Christophe; Parcq, Jérôme.
Affiliation
  • Thiebaut AM; Op2Lysis SAS, GIP Cyceron, 14000 Caen, France.
  • Louet ER; Op2Lysis SAS, GIP Cyceron, 14000 Caen, France.
  • Ianszen M; Normandie Univ, UNICAEN, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), 14000 Caen, France.
  • Guichard MJ; Op2Lysis SAS, GIP Cyceron, 14000 Caen, France.
  • Hanley DF; Op2Lysis SAS, GIP Cyceron, 14000 Caen, France.
  • Gaudin C; The Johns Hopkins Medical Institutions, BIOS, Baltimore, MD 21202, USA.
  • Parcq J; Op2Lysis SAS, GIP Cyceron, 14000 Caen, France.
Brain ; 146(11): 4690-4701, 2023 11 02.
Article in En | MEDLINE | ID: mdl-37450572
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrinolysin / Fibrinolytic Agents Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Brain Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrinolysin / Fibrinolytic Agents Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Brain Year: 2023 Type: Article Affiliation country: France